Article info
PDFCommentary
Microbiota as a cornerstone in the development of primary sclerosing cholangitis: paving the path for translational diagnostic and therapeutic approaches
- Correspondence to Dr Catherine Mooser, Department for BioMedical Research (DBMR), University of Bern, 3008 Bern, Switzerland ; catherine.mooser{at}dbmr.unibe.ch
Citation
Microbiota as a cornerstone in the development of primary sclerosing cholangitis: paving the path for translational diagnostic and therapeutic approaches
Publication history
- Received March 28, 2019
- Revised April 16, 2019
- Accepted April 18, 2019
- First published April 26, 2019.
Online issue publication
July 05, 2019
Article Versions
- Previous version (26 April 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.